Capital Investment Counsel, LLC

Position in AMGN — Amgen Inc

CIK 2033609 DENVER, CO

Position in AMGN

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$7,268,110

+$335,962 QoQ

Shares Held

20,071

+1.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

1.82%

of 13F equity value

Holder Rank

#663

of 3,139 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Capital Investment Counsel, LLC holds $30,068,995 across 6 Drug Manufacturers - General names. AMGN ranks #2 (24.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	49,388	$12,427,996
2	AMGN	Amgen Inc This page	20,071	$7,268,110
3	GILD	Gilead Sciences, Inc.	49,570	$6,262,673
4	LLY	ELI LILLY & Co	2,935	$3,520,327
5	JNJ	Johnson & Johnson	1,290	$327,621
6	MRK	Merck & Co., Inc.	2,041	$262,268

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,268,110	20,071	+1.9%	Shares	Sole	2026-07-15
2026-03-31	$6,932,148	19,702	+3.4%	Shares	Sole	2026-04-23
2025-12-31	$6,237,873	19,058	+3.8%	Shares	Sole	2026-02-02
2025-09-30	$5,182,038	18,363	+2.1%	Shares	Sole	2025-11-06
2025-06-30	$5,022,429	17,988	-2.5%	Shares	Sole	2025-08-01
2025-03-31	$5,745,605	18,442	-0.9%	Shares	Sole	2025-05-15
2024-12-31	$4,852,595	18,618	+2.4%	Shares	Sole	2025-01-23
2024-09-30	$5,860,033	18,187	+3.5%	Shares	Sole	2024-11-12
2024-06-30	$5,489,746	17,570	+6.7%	Shares	Sole	2024-08-14
2024-03-31	$4,681,328	16,465	+65.0%	Shares	Sole	2024-08-14
2023-12-31	$2,874,439	9,980	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.